These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37396626)

  • 1. Corrigendum to "Quantitative comparison of the protein corona of nanoparticles with different matrices" [Int J Pharm X 2022 Oct 21;4: 100136].
    Ottonelli I; Duskey JT; Genovese F; Pederzoli F; Caraffi R; Valenza M; Tosi G; Vandelli MA; Ruozi B
    Int J Pharm X; 2023 Dec; 5():100182. PubMed ID: 37396626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum to "Mycosynthesis of silver nanoparticles bearing antibacterial activity" [Saudi Pharm. J. 24 (2016) 140-146].
    Azmath P; Baker S; Rakshith D; Satish S
    Saudi Pharm J; 2017 Jan; 25(1):148. PubMed ID: 28223877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to 'LC-MS metabolomics comparisons of cancer cell and macrophage responses to methotrexate and polymer-encapsulated methotrexate' [International Journal of Pharmaceutics: X Volume 1 (2019) 100036].
    Al-Natour MA; Alazzo A; Ghaemmaghami AM; Kim DH; Alexander C
    Int J Pharm X; 2020 Dec; 2():100044. PubMed ID: 33376977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Inhaled nanoparticles-An updated review" [Int. J. Pharm. 587 (2020) 119671].
    Praphawatvet T; Peters JI; Williams RO
    Int J Pharm; 2020 Oct; 588():119873. PubMed ID: 32950278
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Hepatotoxicity evaluation of dextran stabilized iron oxide nanoparticles in Wistar rats" [Int. J. Pharm. 509(1-2) (2016) 28-34].
    Easo SL; Mohanan PV
    Int J Pharm; 2021 Sep; 607():121028. PubMed ID: 34452792
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Preparation and characterization of Pickering emulsion stabilized by lovastatin nanoparticles for vaccine adjuvants" [Int. J. Pharm. 653 (2024) 123901].
    Zhang Y; Song Z; Zhang Z; Zhang T; Gu P; Feng Z; Xu S; Yang Y; Wang D; Liu Z
    Int J Pharm; 2024 May; 656():124101. PubMed ID: 38616464
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Toxicity, toxicokinetics and biodistribution of dextran stabilized Iron oxide Nanoparticles for biomedical applications" [Int. J. Pharm. 511 (2016) 586-598].
    Remya NS; Syama S; Sabareeswaran A; Mohanan PV
    Int J Pharm; 2021 Sep; 606():120930. PubMed ID: 34332819
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "A narrative review of approved and emerging anti-obesity medications" [Saudi Pharm. J. 31(10) (2023) 101757].
    Beshir SA; Elnour AA; Soorya A; Mohamed AP; Goh SSL; Hussain N; Al Haddad AHI; Hussain F; El Khidir IY; Abdelnassir Z
    Saudi Pharm J; 2024 May; 32(5):102047. PubMed ID: 38596318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum regarding missing Conflict of Interest statements in previously published articles.
    Int J Pharm X; 2022 Dec; 4():100071. PubMed ID: 36573183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "Non-covalent strategies to functionalize polymeric nanoparticles with NGR peptides for targeting breast cancer" [Int. J. Pharm. 633 (2023) 122618].
    Conte C; Longobardi G; Barbieri A; Palma G; Luciano A; Dal Poggetto G; Avitabile C; Pecoraro A; Russo A; Russo G; Laurienzo P; Romanelli A; Quaglia F
    Int J Pharm; 2023 Jun; 641():123045. PubMed ID: 37169105
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Medication safety practices in hospitals: A national survey in Saudi Arabia" [Saudi Pharm. J. 21(2) (2013) 159-164].
    Aljadhey H; Alhossan A; Alburikan K; Adam M; Murray MD; Bates DW
    Saudi Pharm J; 2016 Mar; 24(2):232. PubMed ID: 27013918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to "SN38 conjugated hyaluronic acid gold nanoparticles as a novel system against metastatic colon cancer cells" [Int. J. Pharm. 526(1-2) (2017) 339-352].
    Hosseinzadeh H; Atyabi F; Varnamkhasti BS; Hosseinzadeh R; Ostad SN; Ghahremani MH; Dinarvand R
    Int J Pharm; 2022 Oct; 626():122145. PubMed ID: 36058773
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Characterization of nanoparticles made of ethyl cellulose and stabilizing lipids: Mode of manufacturing, size modulation, and study of their effect on keratinocytes" [Int. J. Pharm. 607 (2021) 121003].
    Zamansky M; Zehavi N; Ben-Shabat S; Sintov AC
    Int J Pharm; 2021 Nov; 609():121177. PubMed ID: 34656377
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Tanshinone-I for the treatment of uterine fibroids: Molecular docking, simulation, and density functional theory investigations" [Saudi Pharm. J. 31(6) (2023) 1061-1067].
    Tiwari A; Tiwari V; Sharma A; Singh D; Singh Rawat M; Virmani T; Virmani R; Kumar G; Kumar M; Alhalmi A; Noman OM; Mothana RA; Alali M
    Saudi Pharm J; 2023 Oct; 31(10):101782. PubMed ID: 37881648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia" [Saudi Pharm. J. 22(5) (2014) 411-418].
    Mahmoud MA; Alsowaida Y; Alshammari T; Khan TM; Alrasheedy A; Hasssali MA; Aljadhey H
    Saudi Pharm J; 2018 Jan; 26(1):144. PubMed ID: 29988824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "GB7 acetate, a
    Li Z; Mao L; Yu B; Liu H; Zhang Q; Bian Z; Zhang X; Liao W; Sun S
    J Pharm Anal; 2023 Dec; 13(12):1580-1582. PubMed ID: 38223445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Design, optimization and pharmacokinetic evaluation of PLGA phosphatidylcholine hybrid nanoparticles of triamcinolone acetonide loaded in situ gel for topical ocular delivery" [Int. J. Pharm. 647 (2023) 123530].
    Shareef Khan M; Rao Ravi P; Shrikant Dhavan D
    Int J Pharm; 2023 Dec; 648():123615. PubMed ID: 38000952
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "New terpenic and phenolic compounds from
    Parvez MK; Al-Dosari MS; Tabish Rehman M; Alajmi MF; Alqahtani AS; AlSaid MS
    Saudi Pharm J; 2021 Dec; 29(12):1513. PubMed ID: 35002389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to "Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers" [Saudi Pharm. J. 29(10) (2021) 1143-1154].
    Bunlung S; Nualnoi T; Issarachot O; Wiwattanapatapee R
    Saudi Pharm J; 2024 Jan; 32(1):101908. PubMed ID: 38111671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods for predicting dissolution and the theoretical implications of particle-size-dependent solubility.
    Johnson KC
    J Pharm Sci; 2012 Feb; 101(2):681-9. PubMed ID: 21989679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.